OrthoSpineNews

APRIL 1, 2025

Yasser Abdalla , Head of Department of Neurosurgery, Nordwest-Krankenhaus, Sanderbusch (Germany), the study highlights the clear advantages of Neo’s platform in reducing early screw loosening and improving patient outcomes by managing unintended mechanical stress during surgery. after one year 3.4 times lower than the 9.2%

Degenerative Disc Disease

OrthoSpineNews

JUNE 23, 2025

ASPIRE pivotal Level-1 PMA IDE study evaluated PearlMatrix vs. local autograft in single-level TLIF procedures: – Demonstrated statistically superior fusion speed; – Achieved over twice as many patients fused at six months; – Included ~60% high-risk patients WESTMINSTER, Colo., 3 The ASPIRE trial included 33 U.S.

Degenerative Disc Disease

OrthoSpineNews

JULY 8, 2025

a global, commercial-stage orthopedics company dedicated to redefining the path to bone repair, today announced the successful completion of the first patient treated with PearlMatrix P-15 Peptide Enhanced Bone Graft following the recent U.S. The system is to be used in patients who have had at least six months of non-operative treatment.

Degenerative Disc Disease

ChiroJunky

JANUARY 1, 2023

Wellness, alignment, and holistic were trend words in 2022, but chiropractic was largely missing from the thread. bring us patients. A 2016 study revealed that almost 50% of participants with degenerative disc disease were also deficient in vitamin D , a vitamin that is notoriously deficient amongst black Americans.

Spine

ChiroJunky

JANUARY 1, 2023

Wellness, alignment, and holistic were trend words in 2022, but chiropractic was largely missing from the thread. bring us patients. A 2016 study revealed that almost 50% of participants with degenerative disc disease were also deficient in vitamin D , a vitamin that is notoriously deficient amongst black Americans.

Spine

OrthoSpineNews

FEBRUARY 10, 2025

million Market structure Fragmented YoY growth 2022-2023 (%) 5.0 Patients benefit from quicker recovery, less postoperative pain, and reduced hospital stays. Patients prefer MISS due to smaller incisions, less scarring, and faster recovery, leading to market growth for spinal implants during the forecast period.

Degenerative Disc Disease